Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pieter Martijn Kolijn"'
Autor:
Pieter Martijn Kolijn, Florentin Späth, Mouhamad Khouja, Paul Hengeveld, Lina van der Straten, Nikos Darzentas, Magnus Hultdin, James D. Mckay, Christiane Pott, Roel C.H. Vermeulen, Anton Langerak
Publikováno v:
HemaSphere, Vol 7, p e61709cf (2023)
Externí odkaz:
https://doaj.org/article/f5b1ded2b4984216b04f71a13ab8b9a1
Autor:
Paul Hengeveld, Joyce Schilperoord-Vermeulen, Michèle van der Klift, Julie Dubois, Pieter Martijn Kolijn, François Kavelaars, Melissa Rijken, Johan Dobber, Kazem Nasserinejad, Sabina Kersting, Peter Westerweel, Arnon Kater, Anton Langerak, Mark-David Levin
Publikováno v:
HemaSphere, Vol 7, p e639493f (2023)
Externí odkaz:
https://doaj.org/article/efdff620d73d440c84258a3bb719f2a0
Autor:
Paul Hengeveld, Pieter Martijn Kolijn, Jeroen Demmers, Wouter Doff, Julie Dubois, Melissa Rijken, Jorn Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten Gussinklo, Peter Valk, Laura Faber, Peter Westerweel, Arnon Kater, Mark-David Levin, Anton Langerak
It remains challenging in chronic lymphocytic leukemia (CLL) to distinguish between patients with favorable and unfavorable time to first treatment (TTFT). Additionally, the downstream protein correlates of well-known molecular features of CLL are no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f2e7a21a90fe755a7c48aee899349ac
https://doi.org/10.21203/rs.3.rs-2312822/v1
https://doi.org/10.21203/rs.3.rs-2312822/v1
